pharmaphorum May 19, 2022
Jonah Comstock

In the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Mohammed Issa, vice president of commercial at US Janssen Neuroscience.

They chat about the current state of mental healthcare and how innovation in pharma is rising to meet the challenges and opportunities created by the COVID-19 pandemic. They also touch on patient centricity, innovation in pharma, recent technological developments, and...

Today's Sponsors

H1
ZeOmega
Holon

Today's Sponsors

Institute for Healthcare Improvement
Crossover Health

Today's Sponsor

Institute for Healthcare Improvement

Continue Reading

 
Topics: Conferences / Podcast, Equity/SDOH, Healthcare System, Mental Health, Pharma, Pharma / Biotech, Provider, Trends
Related Articles:
Opinion: The health care industry’s lax approach to nurses’ mental health needs to change
Vistria Makes Good on Youth Mental Health Pledge, Invests Upwards of $200M in Sandstone Care
What Amazon’s $3.9B Acquisition of One Medical Means for Behavioral Health
The Universal Behavior Model: A Comprehensive Approach to Integrated Care
Digital Mental Health Funding Down 53% In Q2, Coming off Record 2021